BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy

Completed · Phase 1

Conditions studied: Unspecified Adult Solid Tumor, Protocol Specific, Neutropenia

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have cancers that have not responded to previous therapy.

Key facts

Study ID

NCT00020371

Run by

National Cancer Institute (NCI)

Starts

2000-09-01

Last updated by the study team

2024-03-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Medicine Branch — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.